Drug intelligence / Profile preview

lidocaine + esketamine

Development stage
Unknown
Lead developer
West China Hospital of Sichuan University
Modality
Small Molecules
Administration
Intravenous
01

Overview

Lidocaine + esketamine is an intravenous combination therapy being investigated for the management of postoperative pain and recovery, specifically in patients undergoing liver cancer surgery. Lidocaine is a local anesthetic and anti-arrhythmic that acts as a sodium channel blocker, while esketamine (the S-enantiomer of ketamine) is a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist with analgesic and anesthetic properties. The combination aims to leverage multimodal analgesia to reduce opioid consumption and improve postoperative outcomes. This specific study is sponsored by West China Hospital, Sichuan University.

Other names
lidocaine + S-ketamineintravenous lidocaine and S-ketamine
02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on lidocaine + esketamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lidocaine + esketamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call